The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outreach: Preliminary safety and efficacy results from a phase 2 study of lisocabtagene maraleucel (liso-cel) in the nonuniversity setting.
 
John E. Godwin
No Relationships to Disclose
 
Bassam Ibrahim Mattar
Employment - Cancer Center of Kansas
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline
 
Michael B. Maris
No Relationships to Disclose
 
Carlos R. Bachier
Employment - HCA Healthcare
Consulting or Advisory Role - crispr therapeutics (Inst); Juno/Celgene; Kadmon (Inst); Novartis; Viracyte (Inst); WUGEN, Inc. (Inst)
Research Funding - BMS (Inst)
 
Don A. Stevens
No Relationships to Disclose
 
Daanish Hoda
No Relationships to Disclose
 
Juan Carlos Varela
Stock and Other Ownership Interests - NexImmune
Honoraria - Kite, a Gilead Company; NexImmune; Omeros
Consulting or Advisory Role - NexImmune
Speakers' Bureau - Kite, a Gilead Company
 
Mohamad Cherry
No Relationships to Disclose
 
Suzanne R. Fanning
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Incyte; Takeda; TG Therapeutics
Speakers' Bureau - Bristol-Myers Squibb; Sanofi; Takeda
 
James H. Essell
Consulting or Advisory Role - Abbvie/Genentech; Celgene/Bristol-Myers Squibb
Speakers' Bureau - Kite/Gilead
 
Habte Aragaw Yimer
Stock and Other Ownership Interests - Epizyme; Karyopharm Therapeutics
Consulting or Advisory Role - Amgen; AstraZeneca; Karyopharm Therapeutics
Speakers' Bureau - Amgen; AstraZeneca; BeiGene; Janssen; Karyopharm Therapeutics
Research Funding - BeiGene; Janssen
Travel, Accommodations, Expenses - Amgen; AstraZeneca; BeiGene; Janssen; Karyopharm Therapeutics
 
Jay G. Courtright
No Relationships to Disclose
 
Jeff Porter Sharman
Employment - US Oncology Network
Stock and Other Ownership Interests - VelosBio
Consulting or Advisory Role - Abbvie; Acerta Pharma/AstraZeneca; Beigene; Bristol-Myers Squibb; Celgene; Genentech; Pfizer; Pharmacyclics; TG Therapeutics
Research Funding - Acerta Pharma (Inst); Celgene (Inst); Genentech (Inst); Gilead Sciences (Inst); Merck (Inst); Pharmacyclics (Inst); Seagen (Inst); Takeda (Inst); TG Therapeutics (Inst)
 
Nikolaus S. Trede
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Marina Youssef
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
James Lymp
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Paul Shaughnessy
Honoraria - Kite, a Gilead Company; Sanofi; Takeda
Speakers' Bureau - Kite, a Gilead Company; Sanofi; Takeda
Travel, Accommodations, Expenses - Kite, a Gilead Company; Sanofi; Takeda